Skip to content
+49 40 3009799 0 order@oncoscience.de
EnglishEnglish
  • DeutschDeutsch
Oncoscience
  • COMPANY
  • ONCOLOGY
  • PRODUCT
  • RESEARCHExpand
    • CLINICAL TRIALS
    • PUBLICATIONS
  • FAQ
  • NEWS
+49 40 3009799 0 
EnglishEnglish
  • DeutschDeutsch
Oncoscience
NEWS

Oncoscience AG presents results from Phase III study of Nimotuzumab (Theraloc®) in patients with diffuse intrinsic pontine glioma at the 41. SIOP, Sao Paulo, Brazil, October 6th-9th, 2009

ByOncoscience 9. October 2009

Read More Oncoscience AG presents results from Phase III study of Nimotuzumab (Theraloc®) in patients with diffuse intrinsic pontine glioma at the 41. SIOP, Sao Paulo, Brazil, October 6th-9th, 2009Continue

Oncoscience GmbH
Osterbrooksweg 59
22869 Schenefeld
Germany

 

Phone: +49-40 300 9799-0
Fax: +49-40 300 9799-20
Email: order@oncoscience.de

part of

Legal Notice

© 2025 Oncoscience

Scroll to top
  • COMPANY
  • ONCOLOGY
  • PRODUCT
  • RESEARCH
    • CLINICAL TRIALS
    • PUBLICATIONS
  • FAQ
  • NEWS
Search
Diese Website benutzt Cookies. Wenn du die Website weiter nutzt, gehen wir von deinem Einverständnis aus.OKDatenschutzerklärung